Xiaoting Wang Ph.D.

Xiaoting Wang PhD, RAC possesses extensive experience in regulatory affairs within the biotechnology and pharmaceutical sectors. Currently serving as Sr Director of Regulatory Affairs at Entrada Therapeutics, Xiaoting has previously held significant positions such as Director of Regulatory Affairs at ImmunoGen, Inc. and Associate Director of Regulatory Affairs at Kowa Research Institute, Inc. Additionally, Xiaoting contributed to clinical studies as a Clinical Study Specialist at AbbVie, demonstrating a comprehensive background in both regulatory strategy and clinical development.